SCHEMBL13506824

SCHEMBL13506824

Cn1c2cc(N(c3ccccc3)c3ccccc3)ccc2c2c3ccc4c(c3ccc21)c1ccc(N(c2ccccc2)c2ccccc2)cc1n4C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.38
▸ ALDH1A1 P00352 8/20 0.36
▸ KDM4E B2RXH2 7/20 0.36
▸ MAPT P10636 5/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ HPGD P15428 5/20 0.35
▸ HSD17B10 Q99714 4/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ PABPC1 P11940 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ GPR3 P46089 1/20 0.34
▸ KIF11 P52732 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507568 0.94 BCHE (0.38) NQO2ALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL13507575 0.94 MAOB (0.38) NQO2ALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL13507561 0.92 NQO2 (0.33) NQO2ALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL13507026 0.90 KIF11 (0.38) NQO2ALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL18564817 0.90 NQO2 (0.37) NQO2ALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL13506854 0.89 RXRA (0.43) NQO2ALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL17904090 0.88 GPR3 (0.45) ALDH1A1KDM4EMAPTL3MBTL1CYP1A2
SCHEMBL13506831 0.87 ALDH1A1 (0.35) NQO2ALDH1A1KDM4EMAPTHPGD
SCHEMBL13507586 0.87 HTR1D (0.36) LMNA
SCHEMBL18565012 0.86 NQO2 (0.35) NQO2ALDH1A1KDM4EMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 NQO2 768/4885ALDH1A1 119/4885KDM4E 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback